Please complete security verification This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our supportContinue Reading
TOPLINE: Compared with placebo, secukinumab demonstrated superior pain reduction in moderate to severe hidradenitis suppurativa in two phase 3 trials. Improvements in pain were sustained through week 52 and were associated with better quality of life outcomes. METHODOLOGY: Researchers analysed 1084 patients with moderate to severe hidradenitis suppurativa from twoContinue Reading
For older adults living with obesity, the goal of treatment should not just be shedding pounds — it should be improving physical function, preserving independence, and enhancing quality of life. That was the central message from a group of experts who presented on patient-centered approaches to obesity care at theContinue Reading
Please complete security verification This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our supportContinue Reading
Please complete security verification This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our supportContinue Reading
Please complete security verification This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our supportContinue Reading
TOPLINE: A combination of targeted treatment and immunotherapy has revolutionized Philadelphia chromosome–positive acute lymphoblastic leukemia management, achieving long-term survival rates of 75%-80% without systemic chemotherapy or transplantation. METHODOLOGY: Researchers initiated a treatment protocol in 2000 using tyrosine kinase inhibitors plus glucocorticoids for induction without systemic chemotherapy. Analysis included first-, second-,Continue Reading
Please complete security verification This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our supportContinue Reading
Please complete security verification This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our supportContinue Reading
Please complete security verification This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our supportContinue Reading
Skip to content